Suppr超能文献

中医脾胃病元证据原型数据库的构建及其在自动Meta分析系统中的应用

Construction of a Meta-Evidence Prototype Database of Traditional Chinese Medicine Splenogastric Diseases and Its Application in an Automatic Meta-Analysis System.

作者信息

Zhang Xueqin, Wang Chunying, Yao Yanning, Sun Wenyu, Guo Yujie, Ma Lin, Lu Xinyuan, Deng Hongyong

机构信息

TCM Science and Technology Information Center, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

Evid Based Complement Alternat Med. 2022 Jul 13;2022:6933523. doi: 10.1155/2022/6933523. eCollection 2022.

Abstract

BACKGROUND

Traditional Chinese medicine splenogastric diseases (TCMSDs) are equivalent to digestive system diseases in modern medicine. The forms of clinical evidence of TCMSDs include clinical trials, such as randomized controlled trials (RCTs) and systematic reviews (SRs). SRs mainly rely on manual operations and have the shortcomings of time consumption and low efficiency; therefore, they cannot meet the needs of rapid clinical decision-making. It is urgent to establish a new and smart form of a database to support the progress of SRs.

METHODS

We searched and screened all TCMSD RCT reports, in both Chinese and English, and extracted them into meta-evidence through predesigned structural Microsoft Excel tables. All meta-evidence was imported into an online clinical meta-evidence collection and management system after data quality checking. The meta-evidence database of traditional Chinese medicine (TCM) splenogastric disease (MED-TCMSD) was then tested as a backend of an automatic meta-analysis system.

RESULTS

A total of 405 cases of TCMSD RCTs were processed into meta-evidence. The most common diseases were stomach stuffiness disease, epigastralgia, and chronic atrophic gastritis. Banxiaxiexin decoction and its modifications were the most used interventions. More than half of the cases employed TCM in conjunction with regular therapeutics. The top reported outcomes included clinical effects, adverse events, and TCM syndromes. The MED-TCMSD worked well as a part of the automatic meta-analysis system.

CONCLUSIONS

We developed and tested a new form of clinical evidence, meta-evidence, for automatic SR and fast evidence-based decision-making. As an example of the MED, the MED-TCMSD can improve the production and updating efficiency of the evidence of TCMSDs. The methods of constructing the MED-TCMSD can be further applied to the development of MEDs of other diseases.

摘要

背景

中医脾胃疾病相当于现代医学中的消化系统疾病。中医脾胃疾病的临床证据形式包括临床试验,如随机对照试验(RCT)和系统评价(SR)。系统评价主要依靠人工操作,存在耗时且效率低的缺点;因此,无法满足快速临床决策的需求。迫切需要建立一种新的智能数据库形式来支持系统评价的进展。

方法

我们检索并筛选了所有中英文的中医脾胃疾病随机对照试验报告,并通过预先设计的结构化Microsoft Excel表格将其提取为元证据。所有元证据在数据质量检查后导入在线临床元证据收集与管理系统。然后将中医脾胃疾病元证据数据库(MED-TCMSD)作为自动元分析系统的后端进行测试。

结果

共处理了405例中医脾胃疾病随机对照试验病例作为元证据。最常见的疾病是胃脘痞满、胃脘痛和慢性萎缩性胃炎。半夏泻心汤及其加减是最常用的干预措施。超过一半的病例采用中医与常规疗法联合使用。报告最多的结局包括临床疗效、不良事件和中医证候。MED-TCMSD作为自动元分析系统的一部分运行良好。

结论

我们开发并测试了一种新的临床证据形式——元证据,用于自动系统评价和快速循证决策。作为元证据数据库的一个例子,MED-TCMSD可以提高中医脾胃疾病证据的生成和更新效率。构建MED-TCMSD的方法可进一步应用于其他疾病元证据数据库的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4335/9300305/804637a85a12/ECAM2022-6933523.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验